Viral Vectors Market 2020-2024 | Rising Prevalence of Chronic Diseases to Boost Growth | Technavio

Technavio has been monitoring the viral vectors market and it is poised to grow by USD 493.23 mn during 2020-2024, progressing at a CAGR of over 18% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Request a free sample report

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200320005498/en/

The market is concentrated, and the degree of concentration will accelerate during the forecast period. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Rising prevalence of chronic diseases has been instrumental in driving the growth of the market.

Viral Vectors Market 2020-2024: Segmentation

Viral Vectors Market is segmented as below:

Application

• Gene Therapy
• Vaccines

Geographic Segmentation

• Asia
• Europe
• North America
• ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40121

Viral Vectors Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our viral vectors market report covers the following areas:

• Viral Vectors Market Size
• Viral Vectors Market Trends
• Viral Vectors Market Industry Analysis

This study identifies emergence of novel technologies to manufacture viral vectors as one of the prime reasons driving the viral vectors market growth during the next few years.

Viral Vectors Market 2020-2024: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the viral vectors market, including some of the vendors such as Asklepios BioPharmaceutical Inc., Batavia Biosciences BV, Cobra Biologics Ltd., Creative Biogene and FinVector Oy. Backed with competitive intelligence and benchmarking, our research reports on the viral vectors market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Viral Vectors Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist viral vectors market growth during the next five years
• Estimation of the viral vectors market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the viral vectors market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of viral vectors market vendors

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

• Market segmentation by application
• Comparison by application
• Gene therapy - Market size and forecast 2019-2024
• Vaccines - Market size and forecast 2019-2024
• Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Increasing number of R&D activities for development of gene therapies and vaccines using viral vectors
• Rising number of M&A and collaborations
• Emergence of novel technologies to manufacture viral vectors

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Asklepios BioPharmaceutical, Inc.
• Batavia Biosciences BV
• Cobra Biologics Ltd.
• Creative Biogene
• FinVector Oy
• Lonza Group Ltd.
• Merck KGaA
• Novasep Holding SAS
• Oxford Biomedica Plc
• Thermo Fisher Scientific Inc.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200320005498/en/